| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $97.6M | +19.0% |
| Cost of Revenue | $51.9M | +56.1% |
| Gross Profit | $45.7M | -6.3% |
| R&D Expense | $36.3M | -4.1% |
| SG&A Expense | $39.2M | -1.4% |
| Operating Income | -$86.4M | -16.1% |
| Pre-tax Income | -$77.0M | -6.1% |
| Income Tax | $110K | +443.8% |
| Net Income | -$77.1M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $150.5M | +69.5% |
| Accounts Receivable | $26.7M | +28.6% |
| Inventory | $61.4M | -13.3% |
| Current Assets | $249.1M | +29.3% |
| Total Assets | $296.5M | +15.8% |
| Current Liabilities | $65.1M | +35.1% |
| Total Liabilities | $100.6M | +15.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.7M | +69.5% |
| Capital Expenditures | $3.3M | +24.3% |
| Investing Cash Flow | -$3.3M | -26.0% |
| Financing Cash Flow | $77.8M | +5301.5% |
| Free Cash Flow | -$16.0M | +63.9% |
| -6.3% |
| EPS (Basic) | -$0.31 | +8.8% |
| EPS (Diluted) | -$0.31 | +8.8% |
| Stockholders' Equity |
| $196.0M |
| +16.1% |